Sort   by:  
 Page size 
UnknownEvaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Not available
S-EPMC10979753 | biostudies-literature
UnknownRecessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
Not available
S-EPMC9206114 | biostudies-literature
UnknownAutoantibodies against type I IFNs in patients with critical influenza pneumonia.
Not available
S-EPMC9485705 | biostudies-literature
UnknownRespiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency.
Not available
S-EPMC9178406 | biostudies-literature
UnknownRare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Not available
S-EPMC10074346 | biostudies-literature
UnknownX-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Not available
S-EPMC8532080 | biostudies-literature
UnknownInborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Not available
S-EPMC7857407 | biostudies-literature
UnknownThe risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Not available
S-EPMC9173764 | biostudies-literature
UnknownClinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Not available
S-EPMC7666431 | biostudies-literature
UnknownValidation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery.
Not available
S-EPMC8855527 | biostudies-literature
Sort   by:  
 Page size